Park Medi World has received board approval to incorporate a wholly-owned subsidiary as a special purpose vehicle (SPV) for its 550-bed public-private partnership hospital project in Prayagraj. The decision was taken at a board meeting on August 31, 2026.

The proposed entity will be named "Park Medicity Prayagraj Limited" or "Park Hospital Prayagraj Limited," subject to approval by the Ministry of Corporate Affairs. It will operate as a wholly-owned subsidiary, with the listed company holding 100% shareholding along with its nominees.

Incorporation details

The board approved the incorporation during a meeting that commenced at 10:00 am and concluded at 10:55 am on August 31, 2026. The initial cost of subscription is ₹0.15 crore, comprising 1,50,000 equity shares of face value ₹10 each. No governmental or regulatory approvals are required for the incorporation itself.

Project context

This corporate action follows the company’s disclosure on August 26, 2026, regarding winning the bid for the development and operation of the multi-super-speciality hospital in Prayagraj, Uttar Pradesh. The project was awarded under the PPP model by the Prayagraj Municipal Corporation.

Contract highlights

The agreement outlines a construction period of two years, after which Park Medi World will operate the facility under a 45-year lease. The key terms of the contract are summarised below.

Project scope

The contract positions Park Medi World as both the developer and long-term operator of the facility. The 45-year operation lease provides an extended operational mandate following the completion of construction. The planned investment of around ₹200 crore covers the development of the 550-bed hospital in Prayagraj.

Financial structure and government support

The project entails an investment of approximately ₹200 crore, funded through internal accruals. A significant component of this capital outlay is de-risked by state support: the Municipal Corporation of Prayagraj will reimburse ₹76.52 crore towards hospital construction. This concession covers approximately 38% of the total investment.

In consideration for the concession, Park Group will pay an annual fee of ₹18.10 crore, subject to an annual escalation of 3%.

Site details and expansion potential

The hospital will be developed on a 3.22-acre site allotted by the Municipal Corporation. The site is located directly behind Arail Ghat, approximately 3 kilometres from Sangam Ghat by road. The company holds an option to secure an additional 2.47 acres from the fifth year following the Commercial Operations Date (COD), providing headroom for future expansion.

Strategic context in Uttar Pradesh

The Prayagraj project forms part of Park Group’s broader strategy in Uttar Pradesh. Alongside its 360-bed hospital in Agra and an upcoming 400-bed facility in Gorakhpur, the company’s total capacity in the state will reach 1,260 beds upon completion. This positions the group as one of the leading private healthcare providers in the region.

Park Group currently operates 17 hospitals with a combined capacity of around 4,300 beds. With ongoing integrations and expansions, total group capacity is expected to reach approximately 6,300 beds.

Park Medi World has scheduled its 15th Annual General Meeting (AGM) for September 22, 2026. The meeting will be held via video conferencing at 11:00 am to discuss FY26 financial results and approve the annual report.

The company disclosed record financial performance for the fiscal year ended March 31, 2026. Revenue reached ₹27,284 crore, while profit after tax (PAT) stood at ₹7,009 crore. These figures represent growth over the previous year's results.

Financial Performance

The FY26 results reflect steady top-line expansion alongside improved profitability. The following table outlines the key financial metrics compared to FY25:

What the Numbers Show

Net profit growth significantly outpaced revenue growth in FY26. While revenue increased by a marginal 0.49%, net profit expanded by 7.80%. This divergence suggests an improvement in operating margins or favorable non-operating income contributions during the period, enhancing overall return on equity as indicated by the rising net worth.

Dividend Payout

The Board approved a record dividend payout of ₹2,744.38 crore, translating to ₹2.10 per share. This represents a 31% increase over the dividend distributed in FY25, reflecting the company’s commitment to shareholder returns amidst strong cash generation.

AGM Details

Shareholders can participate in the AGM through the VC/OAVM facility. Attendance via this mode will count toward the quorum under Section 103 of the Companies Act, 2013. E-voting facilities are available for remote voting prior to or during the meeting.

Remote e-voting begins on September 18, 2026, at 9:00 am and ends on September 21, 2026, at 5:00 pm. The cut-off date for remote e-voting is September 15, 2026. Shareholders whose email IDs are not registered with the company or depository participants have been sent letters with web links to access the Annual Report and AGM notice.